Industry: Chemical & Material
Published Date: 2024-04-07
Pages: 110 Pages
Report ld: 2824871
Request Sample
Customized Report
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein translation. Salubrinal is a specific inhibitor of ER Stress induced apoptosis.
The global Salubrinal market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Salubrinal is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Salubrinal is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Salubrinal is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Salubrinal include Cayman Chemical, Merck, Bio-Techne, Thermo Fisher Scientific, BioVision, Enzo Biochem, Selleck Chemicals, Adooq Bioscience and LGC, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Salubrinal production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Salubrinal by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Salubrinal, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Salubrinal, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Salubrinal, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Salubrinal sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Salubrinal market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Salubrinal sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Salubrinal production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Salubrinal in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Salubrinal manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Salubrinal sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Salubrinal Product Introduction
1.2 Market by Type
1.2.1 Global Salubrinal Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Market by Application
1.3.1 Global Salubrinal Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Medical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Salubrinal Production
2.1 Global Salubrinal Production Capacity (2019-2030)
2.2 Global Salubrinal Production by Region: 2019 VS 2023 VS 2030
2.3 Global Salubrinal Production by Region
2.3.1 Global Salubrinal Historic Production by Region (2019-2024)
2.3.2 Global Salubrinal Forecasted Production by Region (2025-2030)
2.3.3 Global Salubrinal Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 Taiwan,China
3 Executive Summary
3.1 Global Salubrinal Revenue Estimates and Forecasts 2019-2030
3.2 Global Salubrinal Revenue by Region
3.2.1 Global Salubrinal Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Salubrinal Revenue by Region (2019-2024)
3.2.3 Global Salubrinal Revenue by Region (2025-2030)
3.2.4 Global Salubrinal Revenue Market Share by Region (2019-2030)
3.3 Global Salubrinal Sales Estimates and Forecasts 2019-2030
3.4 Global Salubrinal Sales by Region
3.4.1 Global Salubrinal Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Salubrinal Sales by Region (2019-2024)
3.4.3 Global Salubrinal Sales by Region (2025-2030)
3.4.4 Global Salubrinal Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Salubrinal Sales by Manufacturers
4.1.1 Global Salubrinal Sales by Manufacturers (2019-2024)
4.1.2 Global Salubrinal Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Salubrinal in 2023
4.2 Global Salubrinal Revenue by Manufacturers
4.2.1 Global Salubrinal Revenue by Manufacturers (2019-2024)
4.2.2 Global Salubrinal Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Salubrinal Revenue in 2023
4.3 Global Salubrinal Sales Price by Manufacturers
4.4 Global Key Players of Salubrinal, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Salubrinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Salubrinal, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Salubrinal, Product Offered and Application
4.8 Global Key Manufacturers of Salubrinal, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Salubrinal Sales by Type
5.1.1 Global Salubrinal Historical Sales by Type (2019-2024)
5.1.2 Global Salubrinal Forecasted Sales by Type (2025-2030)
5.1.3 Global Salubrinal Sales Market Share by Type (2019-2030)
5.2 Global Salubrinal Revenue by Type
5.2.1 Global Salubrinal Historical Revenue by Type (2019-2024)
5.2.2 Global Salubrinal Forecasted Revenue by Type (2025-2030)
5.2.3 Global Salubrinal Revenue Market Share by Type (2019-2030)
5.3 Global Salubrinal Price by Type
5.3.1 Global Salubrinal Price by Type (2019-2024)
5.3.2 Global Salubrinal Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Salubrinal Sales by Application
6.1.1 Global Salubrinal Historical Sales by Application (2019-2024)
6.1.2 Global Salubrinal Forecasted Sales by Application (2025-2030)
6.1.3 Global Salubrinal Sales Market Share by Application (2019-2030)
6.2 Global Salubrinal Revenue by Application
6.2.1 Global Salubrinal Historical Revenue by Application (2019-2024)
6.2.2 Global Salubrinal Forecasted Revenue by Application (2025-2030)
6.2.3 Global Salubrinal Revenue Market Share by Application (2019-2030)
6.3 Global Salubrinal Price by Application
6.3.1 Global Salubrinal Price by Application (2019-2024)
6.3.2 Global Salubrinal Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Salubrinal Market Size by Type
7.1.1 US & Canada Salubrinal Sales by Type (2019-2030)
7.1.2 US & Canada Salubrinal Revenue by Type (2019-2030)
7.2 US & Canada Salubrinal Market Size by Application
7.2.1 US & Canada Salubrinal Sales by Application (2019-2030)
7.2.2 US & Canada Salubrinal Revenue by Application (2019-2030)
7.3 US & Canada Salubrinal Sales by Country
7.3.1 US & Canada Salubrinal Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Salubrinal Sales by Country (2019-2030)
7.3.3 US & Canada Salubrinal Revenue by Country (2019-2030)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Salubrinal Market Size by Type
8.1.1 Europe Salubrinal Sales by Type (2019-2030)
8.1.2 Europe Salubrinal Revenue by Type (2019-2030)
8.2 Europe Salubrinal Market Size by Application
8.2.1 Europe Salubrinal Sales by Application (2019-2030)
8.2.2 Europe Salubrinal Revenue by Application (2019-2030)
8.3 Europe Salubrinal Sales by Country
8.3.1 Europe Salubrinal Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Salubrinal Sales by Country (2019-2030)
8.3.3 Europe Salubrinal Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Salubrinal Market Size by Type
9.1.1 China Salubrinal Sales by Type (2019-2030)
9.1.2 China Salubrinal Revenue by Type (2019-2030)
9.2 China Salubrinal Market Size by Application
9.2.1 China Salubrinal Sales by Application (2019-2030)
9.2.2 China Salubrinal Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Salubrinal Market Size by Type
10.1.1 Asia Salubrinal Sales by Type (2019-2030)
10.1.2 Asia Salubrinal Revenue by Type (2019-2030)
10.2 Asia Salubrinal Market Size by Application
10.2.1 Asia Salubrinal Sales by Application (2019-2030)
10.2.2 Asia Salubrinal Revenue by Application (2019-2030)
10.3 Asia Salubrinal Sales by Region
10.3.1 Asia Salubrinal Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Salubrinal Revenue by Region (2019-2030)
10.3.3 Asia Salubrinal Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Salubrinal Market Size by Type
11.1.1 Middle East, Africa and Latin America Salubrinal Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Salubrinal Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Salubrinal Market Size by Application
11.2.1 Middle East, Africa and Latin America Salubrinal Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Salubrinal Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Salubrinal Sales by Country
11.3.1 Middle East, Africa and Latin America Salubrinal Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Salubrinal Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Salubrinal Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Cayman Chemical
12.1.1 Cayman Chemical Company Information
12.1.2 Cayman Chemical Overview
12.1.3 Cayman Chemical Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Cayman Chemical Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Cayman Chemical Recent Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Overview
12.2.3 Merck Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Merck Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Merck Recent Developments
12.3 Bio-Techne
12.3.1 Bio-Techne Company Information
12.3.2 Bio-Techne Overview
12.3.3 Bio-Techne Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Bio-Techne Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Bio-Techne Recent Developments
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Information
12.4.2 Thermo Fisher Scientific Overview
12.4.3 Thermo Fisher Scientific Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Thermo Fisher Scientific Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Thermo Fisher Scientific Recent Developments
12.5 BioVision
12.5.1 BioVision Company Information
12.5.2 BioVision Overview
12.5.3 BioVision Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 BioVision Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 BioVision Recent Developments
12.6 Enzo Biochem
12.6.1 Enzo Biochem Company Information
12.6.2 Enzo Biochem Overview
12.6.3 Enzo Biochem Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Enzo Biochem Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Enzo Biochem Recent Developments
12.7 Selleck Chemicals
12.7.1 Selleck Chemicals Company Information
12.7.2 Selleck Chemicals Overview
12.7.3 Selleck Chemicals Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Selleck Chemicals Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Selleck Chemicals Recent Developments
12.8 Adooq Bioscience
12.8.1 Adooq Bioscience Company Information
12.8.2 Adooq Bioscience Overview
12.8.3 Adooq Bioscience Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Adooq Bioscience Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Adooq Bioscience Recent Developments
12.9 LGC
12.9.1 LGC Company Information
12.9.2 LGC Overview
12.9.3 LGC Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 LGC Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 LGC Recent Developments
12.10 Focus Biomolecules
12.10.1 Focus Biomolecules Company Information
12.10.2 Focus Biomolecules Overview
12.10.3 Focus Biomolecules Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 Focus Biomolecules Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Focus Biomolecules Recent Developments
12.11 AbMole
12.11.1 AbMole Company Information
12.11.2 AbMole Overview
12.11.3 AbMole Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 AbMole Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 AbMole Recent Developments
12.12 Taiclone
12.12.1 Taiclone Company Information
12.12.2 Taiclone Overview
12.12.3 Taiclone Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 Taiclone Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Taiclone Recent Developments
12.13 Hello Bio
12.13.1 Hello Bio Company Information
12.13.2 Hello Bio Overview
12.13.3 Hello Bio Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.13.4 Hello Bio Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Hello Bio Recent Developments
12.14 J&K Scientific
12.14.1 J&K Scientific Company Information
12.14.2 J&K Scientific Overview
12.14.3 J&K Scientific Salubrinal Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.14.4 J&K Scientific Salubrinal Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 J&K Scientific Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Salubrinal Industry Chain Analysis
13.2 Salubrinal Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Salubrinal Production Mode & Process
13.4 Salubrinal Sales and Marketing
13.4.1 Salubrinal Sales Channels
13.4.2 Salubrinal Distributors
13.5 Salubrinal Customers
14 Salubrinal Market Dynamics
14.1 Salubrinal Industry Trends
14.2 Salubrinal Market Drivers
14.3 Salubrinal Market Challenges
14.4 Salubrinal Market Restraints
15 Key Finding in The Global Salubrinal Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Salubrinal was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 145
USD 3950.00
(Single User License)
The global Salubrinal market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 141
USD 2900.00
(Single User License)
The global Salubrinal market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 162
USD 4900.00
(Single User License)
The global market for Salubrinal was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 121
USD 3950.00
(Single User License)
The global market for Salubrinal was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 100
USD 2900.00
(Single User License)
The global Salubrinal market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 4250.00
(Single User License)
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein translation. Salubrinal is a specific inhibitor of ER Stress induced apoptosis.
Published Date: 2024-02-19
Pages: 128
USD 3950.00
(Single User License)
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein translation. Salubrinal is a specific inhibitor of ER Stress induced apoptosis.
Published Date: 2024-01-12
Pages: 103
USD 2900.00
(Single User License)
The global market for Salubrinal was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 145
The global Salubrinal market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 141
The global Salubrinal market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 162
The global market for Salubrinal was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 121
The global market for Salubrinal was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 100
The global Salubrinal market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein translation. Salubrinal is a specific inhibitor of ER Stress induced apoptosis.
Published: 2024-02-19
Pages: 128
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein translation. Salubrinal is a specific inhibitor of ER Stress induced apoptosis.
Published: 2024-01-12
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now